PREDICTIVE ONCOLOGY INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI
1. KSF investigates POAI's proposed sale to Renovaro Inc. 2. Predictive Oncology shareholders to receive preferred stock in 1:1 exchange. 3. Inquiry focuses on adequacy of sale consideration and process.